Which statement best describes the use of Beta-2 agonists in the management of COPD compared to asthma?
Show answer and explanation
Correct answer: LABAs can be monotherapy in COPD but not asthma
In COPD, LABAs can be used as monotherapy because the underlying disease process is different from the eosinophilic inflammation of asthma. However, in asthma, LABAs must be used with an ICS to ensure safety.
Keep practicing
More Beta-2 Agonists questions
- A patient with stable asthma is prescribed a combination of Budesonide and Formoterol. What is the pharmacological category of Budesonide?
- Which of the following intracellular changes occurs immediately after a Beta-2 agonist binds to its receptor on bronchial smooth muscle?
- Which Beta-2 agonist is classified as a 'rescue' medication due to its rapid onset of action and short duration?
- What is the primary reason why Salmeterol should not be used as monotherapy for the treatment of asthma?
- Which electrolyte abnormality is a well-known systemic side effect of high-dose Beta-2 agonist therapy?
- Which of the following drugs is a Long-Acting Beta-2 Agonist (LABA) that, unlike Salmeterol, has a rapid onset of action?